SREN 📈 Swiss Re - Overview

Exchange: SW • Country: Switzerland • Currency: CHF • Type: Common Stock • ISIN: CH0126881561

SREN: Reinsurance, Insurance, Risk Transfer, Property, Casualty, Life, Health

Swiss Re AG is a global provider of wholesale reinsurance, insurance, and other insurance-based forms of risk transfer, operating through a diverse range of segments to cater to various client needs. The company's business is divided into three primary segments: Property & Casualty Reinsurance, Life & Health Reinsurance, and Corporate Solutions, each designed to address specific aspects of risk management. The Property & Casualty Reinsurance segment is further specialized, offering a broad spectrum of reinsurance solutions including property, credit and surety, engineering, aviation, marine, agriculture, retakaful, and facultative reinsurance, as well as casualty reinsurance such as liability, motor, worker's compensation, personal accident, management and professional liability, cyber, and facultative reinsurance solutions.

The Life & Health Reinsurance segment focuses on underwriting life and health insurance products, providing clients with comprehensive coverage against various life and health-related risks. In contrast, the Corporate Solutions segment takes a more tailored approach, offering a range of risk transfer solutions from standard covers and multi-line programs to highly customized solutions designed to meet the unique needs of each client. Swiss Re AG serves a wide array of clients, including stock and mutual insurance companies, public sector and governmental entities, mid-sized and large corporations, and individuals, demonstrating its ability to adapt to different client profiles and risk management requirements.

With a history dating back to 1863, Swiss Re AG is one of the most established players in the reinsurance industry, boasting a rich legacy of providing risk management solutions to its clients worldwide. Headquartered in Zurich, Switzerland, the company is well-positioned to serve both global and regional markets, leveraging its extensive experience and expertise to navigate the complexities of the insurance and reinsurance landscape. For more information, clients and investors can visit the company's website at https://www.swissre.com, with the company's common stock listed under the ISIN CH0126881561 and classified under the GICS Sub Industry of Reinsurance.

Additional Sources for SREN Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

SREN Stock Overview

Market Cap in USD 42,719m
Sector Financial Services
Industry Insurance - Reinsurance
GiC Sub-Industry Reinsurance
IPO / Inception

SREN Stock Ratings

Growth 5y 62.7%
Fundamental -12.8%
Dividend 52.3%
Rel. Strength Industry 49.2
Analysts -
Fair Price Momentum 143.00 CHF
Fair Price DCF 364.01 CHF

SREN Dividends

Dividend Yield 12m 4.81%
Yield on Cost 5y 7.96%
Annual Growth 5y 0.43%
Payout Consistency 87.1%

SREN Growth Ratios

Growth Correlation 3m 77.5%
Growth Correlation 12m 89.3%
Growth Correlation 5y 86.5%
CAGR 5y 10.41%
CAGR/Mean DD 5y 0.78
Sharpe Ratio 12m 1.55
Alpha 20.00
Beta 0.84
Volatility 24.83%
Current Volume 2323.9k
Average Volume 20d 941.7k
What is the price of SREN stocks?
As of December 22, 2024, the stock is trading at CHF 128.50 with a total of 2,323,927 shares traded.
Over the past week, the price has changed by +1.02%, over one month by +3.07%, over three months by +11.44% and over the past year by +42.80%.
Is Swiss Re a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Swiss Re is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -12.83 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SREN as of December 2024 is 143.00. This means that SREN is currently undervalued and has a potential upside of +11.28% (Margin of Safety).
Is SREN a buy, sell or hold?
Swiss Re has no consensus analysts rating.
What are the forecast for SREN stock price target?
According to ValueRays Forecast Model, SREN Swiss Re will be worth about 154.6 in December 2025. The stock is currently trading at 128.50. This means that the stock has a potential upside of +20.3%.
Issuer Forecast Upside
Wallstreet Target Price 135.1 5.2%
Analysts Target Price - -
ValueRay Target Price 154.6 20.3%